Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1238 of 5804
-
Wearable gadget aims to stop falls in neuropathy patients
Symptom relief Recruiting nowThe goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report bett…
Phase: NA • Sponsor: RxFunction Inc. • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Simple spacer could cut hospital visits for seniors with lung disease
Disease control Recruiting nowThis study evaluates whether adding a spacer device to triple inhaled therapy (ICS/LABA/LAMA via pMDI) can reduce acute exacerbations in elderly patients (≥65 years) with stable chronic airway diseases (COPD or asthma) who are classified as high-risk based on GOLD or GINA guideli…
Phase: NA • Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug aims to reverse liver damage from heavy drinking
Disease control Recruiting nowThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study is the first human, open label, dose escalation, and expansion phase I clinical trial aimed at evaluating the safety, tolerability, preliminary efficacy, pharmacokinetic characteristics, biomarker changes, and immunogenicity of CEL001 injection in the treatment of adva…
Phase: PHASE1 • Sponsor: Guangzhou Xiling Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Ear implant aims to silence ringing in the head
Disease control Recruiting nowThis study will test an experimental Tinnitus Implant System that consists of a cochlear implant, sound processor and programming software. The Tinnitus implant is surgically placed under the skin just behind the ear in the mastoid bone. It has an electrode that extends from the …
Phase: NA • Sponsor: Cochlear • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
No drain, no problem? new study tests simpler recovery after stomach cancer surgery
Disease control Recruiting nowThis study aims to compare the effects of using prophylactic abdominal drainage tubes during Enhanced Recovery After Surgery (ERAS) in patients undergoing Laparoscopic Distal Gastrectomy (LDG) for gastric cancer through a multicenter non-inferiority randomized trial. The study is…
Phase: PHASE3 • Sponsor: Zuoyi Jiao • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Pill-Sized camera could spot hidden cancers in lynch syndrome patients
Knowledge-focused Recruiting nowThe impact of small bowel (SB) capsule endoscopy (CE) on the screening (followed by diagnosis and treatment) of (pre)neoplastic lesions of the small bowel in Lynch syndrome (LS) patients is unknown. The iCARE4Lynch study is a retrospective cohort of patients carrying a pathogeni…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Smart insulin pump may shield kidneys in diabetes patients
Disease control Recruiting nowThe main objective of this study is to evaluate the effect of fully automated closed-loop glucose control on renal tissue oxygenation among people with type 2 diabetes and chronic kidney disease. This is a single-center, open-label parallel design study that will compare 26 week…
Phase: NA • Sponsor: Heba Al-Alwan • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug targets eczema itch even when rash is mild
Symptom relief OngoingThe purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half m…
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New antibiotic beads aim to heal bone infections in bedsores
Disease control Recruiting nowThe purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage…
Phase: PHASE2 • Sponsor: Biocomposites Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI takes on diabetes: could a smartphone app beat standard care?
Disease control Recruiting nowPurpose: To evaluate the efficacy of artificial intelligence (AI)-based decision-making technology in managing glycated hemoglobin (HbA1c) and blood glucose levels compared to the control group. Methods: For the AI Intervention group, the patients will be trained to independentl…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New 20-Strain pneumonia vaccine trial launches in china
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to learn about the safety of the 20-valent pneumococcal conjugate vaccine (20vPnC) among adults, children, and infants, as well as the immunogenicity of 20vPnC among infants and children under 2 years of age in China. This vaccine will be given as per…
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
New cocktail of drugs aims to boost stomach cancer treatment
Disease control Recruiting nowImmunotherapy combined with chemotherapy has become the standard first-line treatment regimen for gastric cancer. However, a subset of patients still fail to benefit or derive only limited benefit from this approach. This study aims to evaluate the addition of immunomodulatory EZ…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Hope for takayasu patients: study tests stopping biologic drugs after years of remission
Disease control Recruiting nowTakayasu arteritis is a chronic large-vessel vasculitis affecting the aorta and its major branches. Biologic therapies such as tumor necrosis factor inhibitors and tocilizumab are commonly used in patients with refractory or relapsing disease. However, there is limited evidence r…
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can VR help kids with autism learn social cues?
Symptom relief ENROLLING_BY_INVITATIONAutism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by impairments in social communication and interaction, as well as restricted and repetitive behaviors. Behavioral and educational interventions are considered the most effective approaches to improve …
Phase: NA • Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy aims to stall lung cancer progression
Disease control Recruiting nowThe goal of this clinical trial is to learn if spatially fractionated radiotherapy (SFRT) combined with standard systemic therapy can treat oligoprogressive non-small cell lung cancer (NSCLC) in patients who have progressed after at least one line of systemic therapy. The main qu…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for kids with kidney disease: drug trial targets protein leak
Disease control Recruiting nowThe primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy following ravulizumab IV dosing in pediatric participants with IgAN or IgAVN.
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could magnetic pulses ease cancer nerve pain?
Symptom relief Recruiting nowHigh-frequency repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) has shown its efficacy to alleviate pain in patients suffering from refractory neuropathic pain. rTMS is now considered as 3rd-line therapy (by the French Society for the Study and…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New hope for advanced cancer? ZG005 drug trial begins
Disease control OngoingThis is an open-label, multicenter, Phase II clinical trial, designed to evaluate the efficacy and safety of ZG005 in patients with advanced solid tumors who have previously failed or are intolerant to standard treatment.
Phase: PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New study aims to lift depression in breast cancer survivors with tailored support
Symptom relief Recruiting nowBreast cancer is the most common cancer among women worldwide, and many survivors experience comorbid mental health conditions such as depression and anxiety, which can significantly worsen health outcomes and increase mortality. This large-scale trial in Pakistan aims to evaluat…
Phase: NA • Sponsor: Pakistan Institute of Living and Learning • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC